Bullish
$PAVM groundbreaking PortIO™ Intraosseous Infusion System has achieved multiple important development, regulatory and intellectual property (IP) milestones towards establishing the first commercially available implantable intraosseous vascular access device. Unprecedented six-month maintenance-free implant duration achieved PAVmed, Inc.
  • 9
  • 1